SE9302278D0 - Growth hormone - Google Patents

Growth hormone

Info

Publication number
SE9302278D0
SE9302278D0 SE19939302278A SE9302278A SE9302278D0 SE 9302278 D0 SE9302278 D0 SE 9302278D0 SE 19939302278 A SE19939302278 A SE 19939302278A SE 9302278 A SE9302278 A SE 9302278A SE 9302278 D0 SE9302278 D0 SE 9302278D0
Authority
SE
Sweden
Prior art keywords
pct
date
alkyl
crystals
growth hormone
Prior art date
Application number
SE19939302278A
Other languages
English (en)
Inventor
*Florin-Robertsson Ebba
*Hoekby Elvy
*Lundin Ronny
*Thome Sirkka
*Westin-Sjoedahl Gertrud
*Lundqvist Tomas
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9203175A external-priority patent/SE9203175D0/sv
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE19939302278A priority Critical patent/SE9302278D0/sv
Publication of SE9302278D0 publication Critical patent/SE9302278D0/sv
Priority to US08/424,450 priority patent/US5734026A/en
Priority to PCT/SE1993/000885 priority patent/WO1994010192A1/en
Priority to CA002147482A priority patent/CA2147482C/en
Priority to DE69322654T priority patent/DE69322654T2/de
Priority to EP93924266A priority patent/EP0669934B1/en
Priority to ES93924266T priority patent/ES2126660T3/es
Priority to DK93924266T priority patent/DK0669934T3/da
Priority to AT93924266T priority patent/ATE174602T1/de
Priority to JP51096494A priority patent/JP3470135B2/ja
Priority to AU54011/94A priority patent/AU679012B2/en
Priority to NO19951547A priority patent/NO320171B1/no
Priority to FI952021A priority patent/FI110609B/sv
Priority to HK98114660A priority patent/HK1013299A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE19939302278A 1992-10-28 1993-07-02 Growth hormone SE9302278D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone
AU54011/94A AU679012B2 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained
JP51096494A JP3470135B2 (ja) 1992-10-28 1993-10-27 成長ホルモンの結晶体を製造する方法およびそれにより得られる結晶体
EP93924266A EP0669934B1 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained
PCT/SE1993/000885 WO1994010192A1 (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained
CA002147482A CA2147482C (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained
DE69322654T DE69322654T2 (de) 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
US08/424,450 US5734026A (en) 1992-10-28 1993-10-27 Process for manufacturing crystals of growth hormone and crystals thereby obtained
ES93924266T ES2126660T3 (es) 1992-10-28 1993-10-27 Proceso para la preparacion de cristales de hormona del crecimiento y los cristales asi obtenidos.
DK93924266T DK0669934T3 (da) 1992-10-28 1993-10-27 Fremgangsmåde til fremstilling af krystaller af væksthormon og derved opnåede krystaller
AT93924266T ATE174602T1 (de) 1992-10-28 1993-10-27 Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle
NO19951547A NO320171B1 (no) 1992-10-28 1995-04-24 Fremgangsmate for fremstilling av krystaller av veksthormon eller funksjonelle derivater derav, krystaller fremstilt ved fremgangsmaten, anvendelse av kjemisk forbindelse for fremstilling av krystallene, suspensjon for injeksjon, torrformulering og depotformulering som omfatter krystallene, anvendelse av krystallene for fremstilling av medikament og fremgangsmate for rensing av veksthormon.
FI952021A FI110609B (sv) 1992-10-28 1995-04-27 Förfarande för framställning av tillväxthormonkristaller
HK98114660A HK1013299A1 (en) 1992-10-28 1998-12-22 Process for manufacturing crystals of growth hormone and crystals thereby obtained

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9203175A SE9203175D0 (sv) 1992-10-28 1992-10-28 Growth hormone
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone

Publications (1)

Publication Number Publication Date
SE9302278D0 true SE9302278D0 (sv) 1993-07-02

Family

ID=26661557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939302278A SE9302278D0 (sv) 1992-10-28 1993-07-02 Growth hormone

Country Status (14)

Country Link
US (1) US5734026A (sv)
EP (1) EP0669934B1 (sv)
JP (1) JP3470135B2 (sv)
AT (1) ATE174602T1 (sv)
AU (1) AU679012B2 (sv)
CA (1) CA2147482C (sv)
DE (1) DE69322654T2 (sv)
DK (1) DK0669934T3 (sv)
ES (1) ES2126660T3 (sv)
FI (1) FI110609B (sv)
HK (1) HK1013299A1 (sv)
NO (1) NO320171B1 (sv)
SE (1) SE9302278D0 (sv)
WO (1) WO1994010192A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ES2306477T3 (es) * 1997-09-05 2008-11-01 Altus Pharmaceuticals Inc. Cristales de glicoproteina reticulados por carbohidratos.
US6380357B2 (en) 1997-12-16 2002-04-30 Eli Lilly And Company Glucagon-like peptide-1 crystals
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
EP2409569B1 (en) * 2002-02-20 2017-08-16 Emisphere Technologies, Inc. Method for administering GLP-1 molecules
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
BR0317888A (pt) * 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203319A (es) * 1990-06-04 1992-07-31 Schering Corp Metodo para la preparacion de cristales de alfa-2 interferona.
CN1033034C (zh) * 1990-06-15 1996-10-16 先灵公司 产生结晶白细胞介素－4的方法
DK168790D0 (sv) * 1990-07-13 1990-07-13 Novo Nordisk As
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone

Also Published As

Publication number Publication date
AU5401194A (en) 1994-05-24
AU679012B2 (en) 1997-06-19
FI952021A (sv) 1995-04-27
CA2147482A1 (en) 1994-05-11
DE69322654D1 (de) 1999-01-28
FI952021A0 (sv) 1995-04-27
FI110609B (sv) 2003-02-28
DE69322654T2 (de) 1999-06-17
HK1013299A1 (en) 1999-08-20
US5734026A (en) 1998-03-31
ATE174602T1 (de) 1999-01-15
JP3470135B2 (ja) 2003-11-25
EP0669934A1 (en) 1995-09-06
WO1994010192A1 (en) 1994-05-11
NO951547L (no) 1995-04-24
JPH08505127A (ja) 1996-06-04
CA2147482C (en) 2003-09-23
NO951547D0 (no) 1995-04-24
EP0669934B1 (en) 1998-12-16
ES2126660T3 (es) 1999-04-01
NO320171B1 (no) 2005-11-07
DK0669934T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
SE9302278D0 (sv) Growth hormone
KR860002958A (ko) 살균제의 제법
DE69503604D1 (de) Stabilisierte orthokieselsäure enthaltende zubereitung sowie biologische zubereitung
DE69408666T2 (de) Risperidon pamoate
CA2031766A1 (en) 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same
JPS6425763A (en) Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
FI911411A0 (sv) Kristallin, kristallvattenfri laktitol och förfarande för dess framställning samt användning därav
ES8801217A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
FI930266A0 (sv) Vaterit och förfarande för dess framställning
JPS649978A (en) Perfluoroalkylisoxazole derivative
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
IT1243801B (it) Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione
ES2043070T3 (es) Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
ES2118256T3 (es) Derivados de acido propenoico utiles como fungicidas.
DE69614841T2 (de) Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
DE69232980D1 (de) Pyrroloazepinderivate
UA66832C2 (uk) Термодинамічно стійка модифікація і рематробану, спосіб одержання затравочних кристалів, спосіб одержання термодинамічно стійкої форми раматробану та фармацевтична композиція
JPS6429301A (en) Bactericidal fungicidal compound composition